| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 3546 |
| 1 | PREDNISONE | 3375 |
| 2 | DEXAMETHASONE | 3190 |
| 3 | DEXAMETHASONE 1.5 MG | 3188 |
| 4 | CYCLOPHOSPHAMIDE | 3157 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 3157 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 3157 |
| 7 | METHOTREXATE | 3047 |
| 8 | CLOZAPINE | 2696 |
| 9 | RITUXIMAB | 2617 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIFLUOPERAZINE HYDROCHLORIDE | 41 | 0.3254 |
| 1 | DYCLONINE HYDROCHLORIDE | 28 | 0.2947 |
| 2 | DARIFENACIN HYDROBROMIDE | 96 | 0.1109 |
| 3 | VANCOMYCIN HYDROCHLORIDE | 776 | 0.0928 |
| 4 | PERPHENAZINE | 140 | 0.0671 |
| 5 | HALOPERIDOL DECANOATE | 97 | 0.0557 |
| 6 | ERIBULIN MESYLATE | 208 | 0.0556 |
| 7 | AMISULPRIDE | 316 | 0.0516 |
| 8 | VALGANCICLOVIR | 960 | 0.0503 |
| 9 | PEGFILGRASTIM | 576 | 0.0481 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 9291 |
| 1 | Platinum-based Drug [EPC] | 5051 |
| 2 | Atypical Antipsychotic [EPC] | 4378 |
| 3 | Alkylating Drug [EPC] | 4128 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 3865 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 3813 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 3440 |
| 7 | Microtubule Inhibitor [EPC] | 3009 |
| 8 | Kinase Inhibitor [EPC] | 2993 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 2963 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 546 | 0.0933 |
| 1 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 976 | 0.0437 |
| 2 | Dopamine-2 Receptor Antagonist [EPC] | 326 | 0.0418 |
| 3 | Interleukin-5 Antagonist [EPC] | 25 | 0.0363 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 273 | 0.0313 |
| 5 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 12 | 0.0308 |
| 6 | Provitamin D2 Compound [EPC] | 838 | 0.0282 |
| 7 | Farnesyltransferase Inhibitor [EPC] | 2 | 0.0256 |
| 8 | CD52-directed Cytolytic Antibody [EPC] | 422 | 0.0218 |
| 9 | Rifamycin Antimycobacterial [EPC] | 75 | 0.0215 |